SOPH SOPHiA GENETICS, Inc.
$7.30
SOPHiA GENETICS, Inc. (SOPH) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
Bearish
Selling ran elevated versus SOPH's own trailing one-year pace, with 98% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
10 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
9
34 transactions
Purchases
$0
0 shares
Sales
$1.9M
256,745 shares
Net activity
-$1.9M
purchases less sales
How much of that selling was preplanned? 98% planned / 2% discretionary
10b5-1 plan sales
$1.8M
33 transactions · 251,745 shares
Discretionary sales
$39.4K
1 transaction · 5,000 shares
Largest single sale: $144.5K.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
Last open-market purchase: June 5, 2026 , by CARDOZA GEORGE .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Camblong Jurgi | Executive Chairman | Sell 10b5-1 | 40,172 | $8.13 | $326.5K | 3,395,650 −1.2% of holding | |
| Muken Ross | Chief Executive Officer | Sell 10b5-1 | 9,838 | $8.13 | $80.0K | 660,391 −1.5% of holding | |
| Menu Philippe | Chief Medical Officer | Sell 10b5-1 | 7,394 | $8.13 | $60.1K | 200,993 −3.5% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 7,394 | $8.12 | $60.1K | 545,493 −1.3% of holding | |
| Van Well Daan | Chief Legal Officer | Sell 10b5-1 | 6,168 | $8.12 | $50.1K | 332,716 −1.8% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,284 | $8.12 | $42.9K | 166,887 −3.1% of holding | |
| Valente Manuela | Chief People Officer | Sell 10b5-1 | 4,240 | $8.13 | $34.5K | 206,210 −2% of holding | |
| CARDOZA GEORGE | Chief Financial Officer | Sell 10b5-1 | 1,592 | $8.10 | $12.9K | 306,726 −0.5% of holding | |
| Puylaert Kevin 2 fills | Chief Sales Officer | Sell | 216 | $8.04 | $1.7K | 147,763 −0.1% of holding | |
| CARDOZA GEORGE | Chief Financial Officer | Sell 10b5-1 | 774 | $8.33 | $6.4K | 308,318 −0.3% of holding | |
| Muken Ross | Chief Executive Officer | Sell 10b5-1 | 422 | $8.33 | $3.5K | 670,229 −0.1% of holding | |
| Menu Philippe | Chief Medical Officer | Sell | 5,000 | $7.88 | $39.4K | 208,387 −2.3% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 4,000 | $7.88 | $31.5K | 552,887 −0.7% of holding | |
| Van Well Daan | Chief Legal Officer | Sell 10b5-1 | 6,168 | $7.63 | $47.1K | 338,884 −1.8% of holding | |
| Camblong Jurgi | Executive Chairman | Sell 10b5-1 | 8,500 | $7.66 | $65.1K | 3,435,822 −0.2% of holding | |
| HIBBS KATHY L | Director | Sell 10b5-1 | 6,250 | $8.13 | $50.8K | 96,992 −6.1% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 10,000 | $8.91 | $89.1K | 556,887 −1.8% of holding | |
| HIBBS KATHY L | Director | Sell 10b5-1 | 6,250 | $8.68 | $54.2K | 103,242 −5.7% of holding | |
| Menu Philippe | Chief Medical Officer | Sell 10b5-1 | 5,000 | $8.68 | $43.4K | 213,387 −2.3% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,000 | $8.80 | $44.0K | 172,171 −2.8% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 5,408 | $8.40 | $45.4K | 566,887 −0.9% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 4,592 | $8.41 | $38.6K | 572,295 −0.8% of holding | |
| Valente Manuela | Chief People Officer | Sell 10b5-1 | 10,000 | $7.94 | $79.4K | 210,450 −4.5% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 10,000 | $7.94 | $79.4K | 576,887 −1.7% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,000 | $8.20 | $41.0K | 177,171 −2.7% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 4,000 | $7.52 | $30.1K | 586,887 −0.7% of holding | |
| Menu Philippe | Chief Medical Officer | Sell 10b5-1 | 5,000 | $7.52 | $37.6K | 218,387 −2.2% of holding | |
| Camblong Jurgi | Executive Chairman | Sell 10b5-1 | 8,500 | $7.61 | $64.7K | 3,444,322 −0.2% of holding | |
| Camblong Jurgi | Executive Chairman | Sell 10b5-1 | 20,000 | $7.23 | $144.5K | 3,452,822 −0.6% of holding | |
| Xu Zhenyu 2 fills | Chief Scientific Officer | Sell 10b5-1 | 17,000 | $7.29 | $123.9K | 600,887 −2.8% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,000 | $7.60 | $38.0K | 182,171 −2.7% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 3,000 | $7.00 | $21.0K | 600,887 −0.5% of holding | |
| Camblong Jurgi | Executive Chairman | Sell 10b5-1 | 20,000 | $6.92 | $138.4K | 3,472,822 −0.6% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 10,000 | $6.92 | $69.2K | 600,887 −1.6% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,000 | $6.95 | $34.8K | 187,171 −2.6% of holding | |
| Menu Philippe | Chief Medical Officer | Sell 10b5-1 | 5,000 | $5.66 | $28.3K | 223,387 −2.2% of holding | |
| Camblong Jurgi | Executive Chairman | Sell 10b5-1 | 20,000 | $6.63 | $132.7K | 3,492,822 −0.6% of holding | |
| Camblong Jurgi 2 fills | Executive Chairman | Sell 10b5-1 | 24,381 | $6.29 | $153.4K | 3,512,822 −0.7% of holding | |
| Menu Philippe | Chief Medical Officer | Sell 10b5-1 | 5,000 | $5.70 | $28.5K | 228,387 −2.1% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 4,000 | $5.70 | $22.8K | 610,887 −0.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.